Targeting B-Cell Receptor Signaling for Anticancer Therapy

“Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton’s Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies” by Adrian Wiestner

Read the accompanying article: http://ascopubs.org/doi/full/10.1200/JCO.2012.44.4281